{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:38:47Z","timestamp":1760985527970},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2003,4,8]],"date-time":"2003-04-08T00:00:00Z","timestamp":1049760000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2003,6]]},"DOI":"10.1007\/s00213-003-1447-5","type":"journal-article","created":{"date-parts":[[2016,11,12]],"date-time":"2016-11-12T18:27:54Z","timestamp":1478975274000},"page":"449-450","source":"Crossref","is-referenced-by-count":2,"title":["Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy\/MDMA users"],"prefix":"10.1007","volume":"167","author":[{"given":"A. C.","family":"Parrott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Buchanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. M.","family":"Heffernan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Scholey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,4,8]]},"reference":[{"key":"1447_CR1","doi-asserted-by":"crossref","unstructured":"Caine DB, Langston JW, Martin WRW (1985) Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease. Nature 317:246\u2013248","DOI":"10.1038\/317246a0"},{"key":"1447_CR2","doi-asserted-by":"crossref","unstructured":"Davis GC, Williams AC, Markey SP (1979) Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiat Res 1:249\u2013254","DOI":"10.1016\/0165-1781(79)90006-4"},{"key":"1447_CR5","first-page":"917","volume":"165","author":"Kalant","year":"2001","unstructured":"Kalant H (2001) The pharmacology and toxicology of \"ecstasy\" (MDMA) and related drugs. Can Med Assoc J 165:917\u2013928","journal-title":"Can Med Assoc J"},{"key":"1447_CR3","doi-asserted-by":"crossref","unstructured":"Langston JW, Ballard P, Tetrud JW, Irwin L (1983) Chronic Parkinsonism in humans due to a product of meperidine-analogue synthesis. Science 219:979\u2013980","DOI":"10.1126\/science.6823561"},{"key":"1447_CR4","doi-asserted-by":"crossref","unstructured":"Langston JW, Ballard P (1984) Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): implications for treatment and pathogenesis of Parkinson's disease. Can J Neurol Sci 11:160\u2013165","DOI":"10.1017\/S0317167100046333"},{"key":"1447_CR6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/00002018-199615020-00003","volume":"15","author":"McCann","year":"1996","unstructured":"McCann UD, Slate SO, Ricaurte GA (1996) Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; \"Ecstasy\"). Drug Safety 15:107\u2013115","journal-title":"Drug Safety"},{"key":"1447_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s002130050714","volume":"139","author":"Parrott","year":"1998","unstructured":"Parrott AC, Lasky J (1998) Ecstasy (MDMA) effects upon mood and cognition; before, during, and after a Saturday night dance. Psychopharmacology 139:261\u2013268","journal-title":"Psychopharmacology"},{"key":"1447_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/hup.415","volume":"17","author":"Parrott","year":"2002","unstructured":"Parrott AC, Buchanan T, Scholey AB, Heffernan TM, Ling J, Rodgers J (2002) Ecstasy\/MDMA attributed problems reported by novice, moderate and heavy users. Hum Psychopharmacol 17:309\u2013312","journal-title":"Hum Psychopharmacol"},{"key":"1447_CR9","unstructured":"Peroutka SJ, Newman H, Harris H (1988) Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology 1:273\u2013277"},{"key":"1447_CR10","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1126\/science.1074501","volume":"297","author":"Ricaurte","year":"2002","unstructured":"Ricaurte GA, Yuan J, Hatzidimitriou G, Cord BJ, McCann UD (2002) Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA (\"Ecstasy\"). Science 297:2260\u20132263","journal-title":"Science"},{"key":"1447_CR11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s002130000467","volume":"151","author":"Rodgers","year":"2000","unstructured":"Rodgers J (2000) Cognitive performance amongst recreational users of \"ecstasy\". Psychopharmacology 151:19\u201324","journal-title":"Psychopharmacology"},{"key":"1447_CR12","doi-asserted-by":"crossref","unstructured":"Scholey AB, Parrott AC, Buchanan T, Heffernan TM, Ling J, Rodgers J (2003) Increased intensity of ecstasy and polydrug use in the more experienced ecstasy users. Addict Behav (in press)","DOI":"10.1016\/j.addbeh.2004.02.022"},{"key":"1447_CR13","doi-asserted-by":"crossref","unstructured":"Snyder SH (1984) Clues to aetiology from a toxin. Nature 311:514","DOI":"10.1038\/311514a0"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-003-1447-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-003-1447-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-003-1447-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-003-1447-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T14:40:46Z","timestamp":1568558446000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-003-1447-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4,8]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["1447"],"URL":"https:\/\/doi.org\/10.1007\/s00213-003-1447-5","relation":{},"ISSN":["0033-3158"],"issn-type":[{"value":"0033-3158","type":"print"}],"subject":[],"published":{"date-parts":[[2003,4,8]]}}}